In vitro processing of human tumor necrosis factor-alpha.
about
Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substratesWhat you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA.Protease inhibition as new therapeutic strategy for GI diseasesUp-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacinIdentification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteasesProteinase 3 is an IL-32 binding proteinInter-alpha inhibitor protein administration improves survival from neonatal sepsis in miceProtein targets of inflammatory serine proteases and cardiovascular disease.Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.Proteinase 3 and prognosis of patients with acute myocardial infarction.Identification of constitutively active interleukin 33 (IL-33) splice variant.Contradictory functions (activation/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activityMolecular and cellular mechanisms of ectodomain sheddingIL-32, a novel cytokine with a possible role in diseaseNeutrophil serine proteases fine-tune the inflammatory responseConverting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3Development of an interleukin (IL)-33 sandwich ELISA kit specific for mature IL-33.Carrageenan primes leukocytes to enhance lipopolysaccharide-induced tumor necrosis factor alpha production.Efficacy of Omega Fatty Acid Supplementation on mRNA Expression Level of Tumor Necrosis Factor Alpha in Patients with Gastric Adenocarcinoma.Proteinase 3 Induces Neuronal Cell Death Through Microglial Activation.A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.Membrane protein secretasesShedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.TNFα cleavage beyond TACE/ADAM17: matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis.Human proteinase 3 can inhibits LPS-mediated TNF-alpha production through CD14 degradation: lack of influence of antineutrophil cytoplasmic antibodies.Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2.The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation.Effects of elastase and cathepsin G on the levels of membrane and soluble TNFalpha.Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages.Clinical characteristics and the expression profiles of inflammatory cytokines/cytokine regulatory factors in asymptomatic patients with nodular gastritis.Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis.Analysis of two common alpha 1-antitrypsin deficiency alleles (PI*Z and PI*S) in subjects with periodontitis.The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.Influence of Charge Distribution at the Active Site Surface on the Substrate Specificity of Human Neutrophil Protease 3 and ElastaseProteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases
P2860
Q24301375-CD59B276-2395-4827-8522-A24C921D9A02Q24791178-159CC21F-9A9B-4CFE-A50E-A36E2300E63DQ26747722-6965E71F-F82F-4A92-8E12-9B94DF836FC2Q28189621-40426481-FABB-4B03-AECB-5FECF3DADA90Q28249632-FE57E5C3-9AE1-4CD7-90B9-3C0EAFA10930Q33234335-AF99AB63-0E74-44B2-8B21-A3677875691CQ34084719-8026169F-8479-46C2-8A93-47A92DF41172Q34114355-2928477F-761A-43ED-95CD-D31323AE93E7Q34149948-3732FB9E-FA32-4C42-B105-EA922FDD1A2FQ34222217-C6DA269E-9242-497E-8CC6-F28ADD9F5BA8Q34394925-5EA4D6AE-A72F-4A0C-83B6-969BFCE27CD9Q35011144-BAF943A9-83DE-4744-A339-3F241EA1572EQ35868166-E7F41620-4E58-4240-B624-9C8BA61EBEA5Q36210626-5F1134CF-B990-4293-AD1D-8A67E16A4551Q36622391-EA5DA9E2-295D-4B8F-B4E5-09BA3AABA1ACQ36737987-D5F0B5FE-AA9C-4F38-9E44-38FF922D0AFAQ37203389-F7B5CE26-FA1B-4B22-BF97-2295674C0707Q38777209-509A9268-BCF7-4357-AAD4-6533B5EF3F6AQ39612912-EC148FD7-5700-4F9F-8AFF-60E5CBC786A3Q39773760-33B758DA-D027-4186-822A-6767C24B2EA1Q40562374-231E622E-EB2E-434D-9980-00FA3EF30D7CQ40993947-5107EB3C-10A5-401E-B958-4AB10BFF46D0Q41341215-025D13E0-F38A-4A15-9B46-4E24498060BAQ42487291-6A59B4AE-D990-4316-89D1-060A8D9CC169Q43077204-B2910528-441B-48FC-8F49-6E89C405C9AEQ44029848-3076CFBD-8F2B-49AF-B12A-0C84EF4124B1Q44090706-493E6533-8B3A-4A51-AD47-1845B6C50537Q44681169-CBA31DD8-E6C0-47C7-B629-C3D81298C5D1Q46733359-294D92D4-F935-487A-8213-6799E3F8C2ADQ46740264-2C20975A-71F8-48C2-AF60-B37D7157696EQ51364111-7B9EB72A-FA59-4B9B-BFD7-185F17262B28Q53306185-C97E08E7-3EC8-4AEB-B221-674A318A01C8Q53488703-C5A056AB-1D07-4CAF-B0AC-242CDF5B14EBQ54799450-52CE9E1F-B53D-4396-AF8B-A0853724B1DAQ55259593-154544AD-14C6-4464-8019-EC32DAC9DA11Q57235374-4152AECF-6377-461E-8DFC-52ED4F5F10B3Q58711278-33B29880-5838-4CCD-915C-8668F673D71C
P2860
In vitro processing of human tumor necrosis factor-alpha.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
In vitro processing of human tumor necrosis factor-alpha.
@en
type
label
In vitro processing of human tumor necrosis factor-alpha.
@en
prefLabel
In vitro processing of human tumor necrosis factor-alpha.
@en
P2093
P2860
P356
P1476
In vitro processing of human tumor necrosis factor-alpha
@en
P2093
J M Bruneau
S Robache-Gallea
P2860
P304
23688-23692
P356
10.1074/JBC.270.40.23688
P407
P577
1995-10-01T00:00:00Z